Suppr超能文献

α1-酸性糖蛋白与丙吡胺及单-N-去烷基丙吡胺在全血中的分布关系

Relationship between alpha 1-acid glycoprotein and distribution of disopyramide and mono-N-dealkyldisopyramide in whole blood.

作者信息

Bredesen J E, Kierulf P

出版信息

Br J Clin Pharmacol. 1986 Sep;22(3):281-6. doi: 10.1111/j.1365-2125.1986.tb02888.x.

Abstract

The binding of disopyramide (DP) and mono-N-dealkyldisopyramide (MND) was measured by equilibrium dialysis in spiked whole blood (10 mumol l-1 DP or MND) from 50 patients having a serum concentration of alpha 1-acid glycoprotein (AAG) ranging from 0.40 to 3.14 g l-1, as well as in whole blood from five healthy subjects, spiked with different concentrations of AAG ranging from 0.61 to 3.33 g l-1. The binding ratio (moles bound divided by moles unbound) in all samples increased from 1.0 to 8.0 for DP and 0.6 to 3.3 for MND with increasing AAG concentrations. The binding varied according to the AAG concentrations both in patients and healthy subjects. Similarly total and free plasma concentrations of DP and MND were also measured. With increasing AAG concentrations the total concentrations measured increased from 9.0 to 15.9 mumol l-1 for DP and from 6.8 to 11.8 mumol l-1 for MND whereas the free concentrations decreased from 3.8 to 0.5 mumol l-1 for DP and from 5.0 to 2.0 mumol l-1 for MND. With increasing AAG concentrations the whole blood/plasma concentration ratio decreased from 1.11 and 1.47 to 0.63 and 0.85 for DP and MND respectively. The ratio between their concentration in cells and the unbound concentration in plasma, however, was constant over the whole AAG concentration range. The mean ratios for all samples were 3.0 and 3.1 for DP and MND respectively, indicating that both compounds are bound or distributed to the blood cells. The distribution of the drugs in whole blood changed according to increasing AAG concentrations.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

通过平衡透析法测定了50例血清α1 -酸性糖蛋白(AAG)浓度范围为0.40至3.14 g/l的患者以及5名健康受试者的加标全血(10 μmol/l双异丙吡胺或单N -去烷基双异丙吡胺)中双异丙吡胺(DP)和单N -去烷基双异丙吡胺(MND)的结合情况。这5名健康受试者的全血中加入了浓度范围为0.61至3.33 g/l的不同浓度AAG。随着AAG浓度增加,所有样本中DP的结合率(结合摩尔数除以未结合摩尔数)从1.0增至8.0,MND的结合率从0.6增至3.3。患者和健康受试者的结合情况均随AAG浓度而变化。同样地,还测定了DP和MND的血浆总浓度和游离浓度。随着AAG浓度增加,测定的DP总浓度从9.0增至15.9 μmol/l,MND从6.8增至11.8 μmol/l,而DP的游离浓度从3.8降至0.5 μmol/l,MND从5.0降至2.0 μmol/l。随着AAG浓度增加,DP和MND的全血/血浆浓度比分别从1.11和1.47降至0.63和0.85。然而,它们在细胞中的浓度与血浆中未结合浓度的比值在整个AAG浓度范围内保持恒定。所有样本中DP和MND的平均比值分别为3.0和3.1,表明这两种化合物均与血细胞结合或分布于血细胞中。全血中药物的分布随AAG浓度增加而变化。(摘要截短至250字)

相似文献

3
Plasma binding of disopyramide and mono-N-dealkyldisopyramide.丙吡胺及单-N-去烷基丙吡胺的血浆结合情况。
Br J Clin Pharmacol. 1982 Nov;14(5):673-6. doi: 10.1111/j.1365-2125.1982.tb04955.x.
4
A simple method for the simulation of unbound serum disopyramide concentration in patients.
J Pharmacobiodyn. 1991 Sep;14(9):493-9. doi: 10.1248/bpb1978.14.493.

本文引用的文献

1
Plasma binding of disopyramide.丙吡胺的血浆结合
Br J Clin Pharmacol. 1980 Jun;9(6):614-8. doi: 10.1111/j.1365-2125.1980.tb01090.x.
5
Plasma binding of disopyramide and mono-N-dealkyldisopyramide.丙吡胺及单-N-去烷基丙吡胺的血浆结合情况。
Br J Clin Pharmacol. 1982 Nov;14(5):673-6. doi: 10.1111/j.1365-2125.1982.tb04955.x.
6
Pharmacology of commonly used antiarrhythmic drugs and comments on the use of therapeutic drug monitoring.
Ther Drug Monit. 1982;4(1):1-14. doi: 10.1097/00007691-198204000-00001.
8
Effect of heparin on the red blood cell-to-plasma concentration ratio of diphenylhydantoin and prazosin.
Ther Drug Monit. 1983;5(4):497-9. doi: 10.1097/00007691-198312000-00019.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验